• Directory of Taiwan

Nuclear Medicine/Radiopharmaceuticals Market [NEWS] 2022 Industry Overview, New Market Opportunities Size, Share, Demands 2030

Quadintel published a new report on the Nuclear Medicine/Radiopharmaceuticals Market. The research report consists of thorough information about demand, growth, opportunities, challenges, and restraints. In addition, it delivers an in-depth analysis of the structure and possibility of global and regional industries.

Global Nuclear Medicine/Radiopharmaceuticals Market is valued approximately USD 4.80 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.0% over the forecast period 2022-2028.

Nuclear medicine is also known as radiopharmaceuticals or medicinal radio compounds, which is a set of pharmaceutical drugs that comprises radioactive isotopes. Nuclear medicine is a form of medical specialty that includes the application of radioactive substances in the diagnosis and treatment of target diseases.

Request To Download Sample of This Strategic Report: –

The growing incidence and prevalence of target conditions such as cancer, cardiovascular, and neurological disorders, rising awareness of radiopharmaceuticals, and rising development of the alpha-radioimmunotherapy-based targeted cancer treatments are the primary factors that are surging the market demand across the globe. According to the National Cancer Institute, in 2018, cancer was is one of the major reasons for the highest deaths accounting for 18.1 million new cases and 9.5 million cancer-related deaths globally. Also, it is expected that the amount will reach 29.5 million and the number of cancer-related deaths to 16.4 million by the end of 2040. Thereby, the rising prevalence of cancer is propelling demand for radiopharmaceuticals, thus, in turn, impelling the market growth. Moreover, the rising inclination towards the Single photon emission computed tomography (SPECT) and positron emission tomography (PET) scans and the increasing number of initiatives to meet the demand & supply gap of Mo-99 is further accelerating the market growth. However, the short half-life of radiopharmaceuticals and hospital budget cuts, and high equipment costs impede the growth of the market over the forecast period of 2022-2028. Also, the use of radiopharmaceuticals in neurological applications and growing investment in R&D activities are anticipated to act as a catalyzing factor for the market demand during the forecast period.

The key regions considered for the global Nuclear Medicine/Radiopharmaceuticals market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Asia-Pacific is the leading region across the world in terms of market share owing to the development of novel technologies for radioisotope production, growing incidences of Alzheimer’s disease, Parkinson’s disease, and availability of government funding. Whereas, North America is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as the increasing R&D expenditure, as well as the rising presence of the leading market players in the region, would create lucrative growth prospects for the Nuclear Medicine/Radiopharmaceuticals market across the North American region.

Request a Sample PDF copy of the report @

Major market players included in this report are:

Cardinal Health Inc.

GE Healthcare Company

Curium SAS

Lantheus Medical Imaging Inc.

Bayer AG

Bracco Imaging Inc.

Eczacybay-Monrol Nuclear Products

Nordion Inc.

Advanced Accelerator Applications

NTP Radioisotopes SOC Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type

Diagnostic Nuclear Medicine

Therapeutic Nuclear Medicine

Brachytherapy Isotopes

By Application

SPECT Applications

PET Applications

Therapeutic Applications

By Procedural Volume Assessment

Diagnostic Procedures

Therapeutic Procedures


By Region:

North America










Asia Pacific





South Korea


Latin America



Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020

Base year – 2021

Forecast period – 2022 to 2028

Target Audience of the Global Nuclear Medicine/Radiopharmaceuticals Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers


Access full Report Description, TOC, Table of Figure, Chart, etc. @ –

Table of Contents:

  • Market Overview
  • Market Definition and Scope
  • Market Dynamics
  • Market Industry Analysis
  • Market, Regional Analysis
  • Analysis of Leading Companies
  • Competitive Intelligence
  • Research Process
  • Market Analysis and Forecast, By Product Types

Factors Influencing

The global market is forecast to witness a rapid growth, owing to increasing demand for technological advancements from end-users. Moreover, increasing investments in research and development activities, launches, partnerships, and other strategic initiatives will benefit the market. Furthermore, the growing focus of authorities towards increasing urbanization and industrialization is forecast to drive the market growth.

What aspects regarding the regional analysis Market are included in this report?

  • Geographical regions covered in the report include North America, Europe, Asia Pacific, Latin America and Middle East and Africa region.
  • The report consists of detailed region-wise analysis of current and future market trends, providing information on product usage and consumption.
  • The growth rate of the market in every region, including their countries over the forecast period is included in the market report.
  • Based on what factors are the key market players assessed in this report?
  • The report offers detailed analysis of leading companies in the market across the globe.
  • It provides details of the major vendors involved in the Market including Key Players
  • A comprehensive overview of each company including the company profile, generated revenue, pricing of goods and
  • the manufactured products is incorporated in the report.
  • The facts and figures about market competitors along with standpoints of leading market players are presented in the report.
  • The recent developments, mergers and acquisitions related to mentioned key players are provided in the market report.

Request Full Report : –

About Quadintel:

We are the best market research reports provider in the industry. Quadintel believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Quadintel is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:

Address: Office – 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
Tel: +1 888 212 3539 (US – TOLL FREE)